Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) ('Apimeds” or the 'Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally ...

Perimeter Acquisition Corp. I (Nasdaq: PMTRU) (the 'Company”), a special purpose acquisition company, today announced the pricing of its upsized initial public offering of 21,000,000 units at $10.00 ...

ASAS Makeen Real Estate Development Co. set its initial public offering (IPO) price at SAR 80 per share, financial advisor ...